Showing results (881-890 of 964) with videos related to

Sort By:
Pageof 97
The New England Journal of Medicine|April 24, 2013
Sofosbuvir for previously untreated chronic hepatitis C infectionEric Lawitz, Alessandra Mangia, David Wyles, et al.
Nature Methods|June 23, 2014
All-optical electrophysiology in mammalian neurons using engineered microbial rhodopsinsDaniel R Hochbaum, Yongxin Zhao, Samouil L Farhi, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2005
4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17beta-hydroxysteroid dehydrogenase. Part 2. SARDavid Gunn, Christiana Akuche, Jeremy Baryza, et al.
The New England Journal of Medicine|July 2, 2021
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin AmyloidosisJulian D Gillmore, Ed Gane, Jorg Taubel, et al.
The International Journal on Drug Policy|June 24, 2025
Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use: the SHARP-C studyJoshua Ang, Behzad Hajarizadeh, Shane Tillakeratne, et al.
Alimentary Pharmacology & Therapeutics|September 27, 2024
Eight-year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trialsMaria Buti, Young-Suk Lim, Henry Lik Yuen Chan, et al.
Clinical and Molecular Hepatology|January 8, 2024
Efficacy, safety, and pharmacokinetics of capsid assembly modulator linvencorvir plus standard of care in chronic hepatitis B patientsJinlin Hou, Edward Gane, Rozalina Balabanska, et al.
Pageof 97